![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/422 | (2006.01) |
A61K 31/366 | (2013.01) | ||
A61P 35/02 | (2006.01) | ||
A61K 31/422 | (2013.01) | ||
A61P 35/02 | (2018.01) |
(11) | Patento numeris | 3154536 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15731531.8 |
Europos patento paraiškos padavimo data | 2015-06-09 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-04-19 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-01 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2015/062807 |
Data | 2015-06-09 |
(87) | Numeris | WO 2015/189186 |
Data | 2015-12-17 |
(30) | Numeris | Data | Šalis |
14305873 | 2014-06-10 | EP |
(72) |
HERMINE, Olivier , FR
ARLET, Jean-Benoit , FR
GUILLEM, Flavia , FR
COURTOIS, Genevève , FR
FONTENAY, Michaela , FR
|
(73) |
Institut National de la Santé et de la
Recherche Médicale (INSERM) ,
101, rue de Tolbiac, 75013 Paris,
FR
Fondation Imagine , 24, Boulevard du Montparnasse, 75015 Paris, FR Assistance Publique-Hôpitaux de Paris (APHP) , 3, avenue Victoria, 75004 Paris, FR Université Paris Cité , 85 boulevard Saint-Germain, 75006 Paris, FR Centre National de la Recherche Scientifique (C.N.R.S.) , 3, rue Michel-Ange, 75016 Paris, FR |
(54) | XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME |
XPO1 ANTAGONIST KPT-251 FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME |